CXCL12 and cancer: They found that nano-PIT inhibited the secretion of C-X-C motif chemokine ligand 12 (CXCL12) and ECM deposition regulated by untreated CAFs, mediating T cell exclusion and preventing physical contact between T cells and cancer cells (161).